JP2016533332A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016533332A5 JP2016533332A5 JP2016516958A JP2016516958A JP2016533332A5 JP 2016533332 A5 JP2016533332 A5 JP 2016533332A5 JP 2016516958 A JP2016516958 A JP 2016516958A JP 2016516958 A JP2016516958 A JP 2016516958A JP 2016533332 A5 JP2016533332 A5 JP 2016533332A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- nanoparticle
- self
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361881848P | 2013-09-24 | 2013-09-24 | |
| US61/881,848 | 2013-09-24 | ||
| PCT/US2014/057240 WO2015048149A1 (en) | 2013-09-24 | 2014-09-24 | Self-assembled nanoparticle vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016533332A JP2016533332A (ja) | 2016-10-27 |
| JP2016533332A5 true JP2016533332A5 (OSRAM) | 2017-11-02 |
Family
ID=51662365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016516958A Ceased JP2016533332A (ja) | 2013-09-24 | 2014-09-24 | 自己集合型ナノ粒子ワクチン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20150110825A1 (OSRAM) |
| EP (1) | EP3049107A1 (OSRAM) |
| JP (1) | JP2016533332A (OSRAM) |
| CA (1) | CA2925201A1 (OSRAM) |
| WO (1) | WO2015048149A1 (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9630994B2 (en) | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| EP3250233A4 (en) | 2015-01-29 | 2018-07-25 | Agency for Science, Technology and Research | Nanocapsules carrying chikungunya-associated peptides |
| WO2017079625A1 (en) * | 2015-11-06 | 2017-05-11 | University Of South Alabama | Novel platform dna vaccine |
| EP3374504B1 (en) * | 2015-11-09 | 2025-03-19 | CureVac SE | Optimized nucleic acid molecules |
| EP3474893A1 (en) | 2016-06-27 | 2019-05-01 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens |
| TWI634899B (zh) * | 2016-11-22 | 2018-09-11 | 國立臺灣大學 | 包含類ｂ肝病毒顆粒作為佐劑的疫苗組成物 |
| TWI683826B (zh) * | 2016-11-22 | 2020-02-01 | 國立臺灣大學 | 重組ｒｓｖ抗原 |
| AU2018249533C1 (en) * | 2017-04-04 | 2023-10-12 | Institute For Research In Biomedicine | Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use |
| DK3661968T3 (da) | 2017-08-04 | 2022-06-20 | Hospital For Sick Children | Nanopartikelplatform til antistof- og vaccineindgivelse |
| SG11202005772YA (en) * | 2018-01-06 | 2020-07-29 | Emergex Vaccines Holding Ltd | Mhc class i associated peptides for prevention and treatment of multiple flavi virus |
| US11771755B2 (en) | 2018-02-28 | 2023-10-03 | University Of Washington | Self-asssembling nanostructure vaccines |
| CA3103088A1 (en) * | 2018-06-08 | 2019-12-12 | Modalis Therapeutics Corporation | Modified cas9 protein and use thereof |
| KR102076917B1 (ko) * | 2018-10-25 | 2020-02-13 | 연세대학교 산학협력단 | 자가조립 나노 입자를 제조하기 위한 유전자 재조합 발현 벡터 시스템 및 이를 이용하는 방법 |
| US12419949B2 (en) | 2019-07-24 | 2025-09-23 | Glaxosmithkline Biologicals Sa | Modified human cytomegalovirus proteins |
| CN112439056B (zh) * | 2019-08-28 | 2022-05-31 | 中国农业科学院生物技术研究所 | 基于自组装铁蛋白纳米抗原颗粒及由其制备的o型口蹄疫疫苗和应用 |
| EP4161570A1 (en) | 2020-06-05 | 2023-04-12 | GlaxoSmithKline Biologicals S.A. | Modified betacoronavirus spike proteins |
| EP4469078A1 (en) | 2022-01-28 | 2024-12-04 | GlaxoSmithKline Biologicals S.A. | Modified human cytomegalovirus proteins |
| CN117567652B (zh) * | 2024-01-19 | 2024-05-14 | 北京安百胜生物科技有限公司 | 一种重组呼吸道合胞病毒颗粒抗原 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR050293A1 (es) * | 2004-08-11 | 2006-10-11 | Moll Tomas | Polipeptidos de interleuquina-15 mutante |
| WO2009033004A1 (en) * | 2007-09-07 | 2009-03-12 | Montana State University | Protein cages and their uses |
| ES2719406T3 (es) * | 2007-12-24 | 2019-07-10 | Id Biomedical Corp Quebec | Antígenos recombinantes del VSR |
| US20110318376A1 (en) * | 2008-12-24 | 2011-12-29 | University Of Rochester | Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins |
| WO2012158613A1 (en) * | 2011-05-13 | 2012-11-22 | Novartis Ag | Pre-fusion rsv f antigens |
| US20130049342A1 (en) * | 2011-08-25 | 2013-02-28 | James Michael Cottrell | Trailer chassis hold down system |
| US9441019B2 (en) * | 2011-09-23 | 2016-09-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Influenza hemagglutinin protein-based vaccines |
| AU2013201495B2 (en) * | 2011-09-30 | 2015-12-03 | Novavax, Inc. | Recombinant nanoparticle RSV F vaccine for respiratory syncytial virus |
| WO2014160463A1 (en) * | 2013-03-13 | 2014-10-02 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Prefusion rsv f proteins and their use |
-
2014
- 2014-09-24 WO PCT/US2014/057240 patent/WO2015048149A1/en not_active Ceased
- 2014-09-24 US US14/495,640 patent/US20150110825A1/en not_active Abandoned
- 2014-09-24 CA CA2925201A patent/CA2925201A1/en not_active Abandoned
- 2014-09-24 JP JP2016516958A patent/JP2016533332A/ja not_active Ceased
- 2014-09-24 EP EP14781401.6A patent/EP3049107A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016533332A5 (OSRAM) | ||
| Pimentel et al. | Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine | |
| JP2015509707A5 (OSRAM) | ||
| JP2022023102A (ja) | 新規多価ナノ粒子に基づくワクチン | |
| JP2015501840A5 (OSRAM) | ||
| US20130236491A1 (en) | Spherical nano and microparticles derived from plant viruses for the display of foreign proteins or epitopes | |
| JP2015508284A5 (OSRAM) | ||
| JP2014500724A5 (OSRAM) | ||
| JP2013517773A5 (OSRAM) | ||
| JP2012095652A5 (OSRAM) | ||
| JP2016501829A5 (OSRAM) | ||
| JP2014507146A5 (OSRAM) | ||
| JP2012501959A5 (OSRAM) | ||
| JP2014502156A5 (OSRAM) | ||
| Mao et al. | Surface display on lactic acid bacteria without genetic modification: strategies and applications | |
| CN117534735A (zh) | 腺病毒外壳蛋白衍生递送载体 | |
| JP2015506705A5 (OSRAM) | ||
| JP2012515557A5 (OSRAM) | ||
| JP2018524019A5 (OSRAM) | ||
| JP2010538619A5 (OSRAM) | ||
| JP2014519817A5 (OSRAM) | ||
| Lee et al. | Nanoglue: an alternative way to display cell-internalizing peptide at the spikes of hepatitis B virus core nanoparticles for cell-targeting delivery | |
| WO2022043449A1 (en) | Vaccines based on an antigen protein fused to a nanostructuring scaffold | |
| JP2019502404A5 (OSRAM) | ||
| CN107344969B (zh) | 一种纳米流感疫苗及构建方法和应用 |